Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can interact with other medications, and the most important thing to understand is that most of those interactions are manageable rather than absolute barriers to treatment. The medicines most commonly affected are those that depend on consistent stomach-emptying times or precise absorption windows. Because tirzepatide slows gastric emptying, it can alter when your body absorbs other drugs, not just whether it does. This is a prescription-only medicine, and every consultation at nume is reviewed by a GPhC-registered Independent Prescriber who checks your full medication list before any treatment is approved.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misreading of drug interaction information is that any listed interaction means you cannot take the medicine. That is rarely the case with Mounjaro. What the interactions mostly mean is that your prescriber needs to know about the other drugs before starting, and may need to monitor or adjust doses as treatment progresses.
Tirzepatide's primary mechanism here is pharmacokinetic rather than pharmacodynamic: by slowing how quickly food and other medicines leave the stomach, it stretches the absorption curve of anything taken by mouth. For most everyday medicines, this produces no clinically significant difference. For a narrow set of drugs where timing matters precisely, it does. The tirzepatide overview covers the medicine's broader mechanism if that context is helpful.
The BNF lists interactions for tirzepatide, and the Mounjaro SmPC published on the eMC is the authoritative reference for prescribers. Worth knowing: neither document presents a long list of absolute contraindications tied to other medicines. The worklist is genuinely short.
Three categories are worth understanding in practical terms.
Diabetes medicines. If you already take insulin or a sulfonylurea such as gliclazide, adding tirzepatide meaningfully lowers blood glucose on top of that effect. Hypoglycaemia becomes a real risk. Prescribers typically reduce the sulfonylurea dose when starting tirzepatide, and insulin adjustments usually follow a structured plan. This is not a reason to avoid the combination, it is a reason to manage it. Pages covering Mounjaro interactions in more depth explore this area further.
Oral contraceptives. NHS England and NHS Inform Scotland both advise that women using the pill add a non-oral contraceptive method, such as condoms, for the first four weeks of Mounjaro treatment and for four weeks after each dose step up. The concern is reduced absorption of the pill during the period when gastric emptying slows most noticeably. There is no equivalent MHRA warning for semaglutide on this point, which makes it specific to tirzepatide's profile rather than a class-wide rule.
Medicines with narrow therapeutic windows. Anticoagulants such as warfarin, certain thyroid medications and some antiepileptics depend on consistent blood levels, and you can read about Mounjaro medication interactions in this group to understand how slowed absorption can theoretically shift those levels. Your prescriber will often ask for monitoring to be continued or tightened in the early weeks. See what medicines interact with Mounjaro for a closer look at this group.
Prescribed drugs are only part of the picture. Over-the-counter painkillers, antacids, herbal supplements and vitamins all count as things your prescriber should know about. St John's Wort, for instance, is a known enzyme inducer that affects the metabolism of several drugs, and it is easily missed in a medication review because people do not always flag supplements alongside prescriptions.
A simple habit: before any consultation, photograph the front of every packet you take regularly, including supplements. It takes under a minute, and it gives our prescribers a complete list without relying on memory. That list is the foundation of a safe interaction review.
For a specific example of a less obvious combination, the tirzepatide and hydroxychloroquine page covers that pairing in detail, including what the evidence actually says.
If you are researching costs alongside safety, the Mounjaro cost page sets out what is included in a private prescription and why clinical review is part of that price rather than an optional extra.
Every application to start treatment includes a medication section that our prescribers read in full before anything is approved. This is not a checkbox exercise. A named GPhC-registered prescriber reads your answers, cross-references your medication list against the Mounjaro SmPC and current BNF guidance, and either approves, requests clarification or declines with an explanation. The NHS notes on weight management medicines confirm that a full clinical assessment is required before any GLP-1 treatment begins.
If your GP has recently changed a prescription, or you have started a new supplement since your last consultation, let us know through the aftercare team. Interactions can emerge mid-treatment as medications change, not just at the start. Our prescribers are available seven days a week for exactly that kind of question.
Speak to our prescribers if you have a complex medication list and want to understand whether Mounjaro is suitable for you. The consultation is free, and the review happens the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.